Anti-CD19 CAR T cell therapy for refractory SLE-ITP.
- DOI
- 10.1016/j.medj.2026.101039
- Published
- 2026 Apr 10
- Container
- Med (New York, N.Y.)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.medj.2026.101039,
title = {Anti-CD19 CAR T cell therapy for refractory SLE-ITP.},
author = {Li M and Zhao J and Lu ZJ and Ning C and Jiang N and Zhang Y and Li Y and Feng Y and Wang Q and Xu D and Leng X and Li J and Zhang S and Wang Z and Peng L and Tian X and Lv L and Zhou D and Zeng X},
year = {2026},
journal = {Med (New York, N.Y.)},
doi = {10.1016/j.medj.2026.101039},
url = {https://doi.org/10.1016/j.medj.2026.101039}
}RIS
TY - JOUR TI - Anti-CD19 CAR T cell therapy for refractory SLE-ITP. AU - Li M AU - Zhao J AU - Lu ZJ AU - Ning C AU - Jiang N AU - Zhang Y AU - Li Y AU - Feng Y AU - Wang Q AU - Xu D AU - Leng X AU - Li J AU - Zhang S AU - Wang Z AU - Peng L AU - Tian X AU - Lv L AU - Zhou D AU - Zeng X PY - 2026 JO - Med (New York, N.Y.) DO - 10.1016/j.medj.2026.101039 UR - https://doi.org/10.1016/j.medj.2026.101039 ER -
APA
M, L., J, Z., ZJ, L., C, N., N, J., Y, Z., Y, L., Y, F., Q, W., D, X., X, L., J, L., S, Z., Z, W., L, P., X, T., L, L., D, Z., & X, Z. (2026). Anti-CD19 CAR T cell therapy for refractory SLE-ITP.. Med (New York, N.Y.). https://doi.org/10.1016/j.medj.2026.101039
Source records
- pubmed · retrieved 2026-09-26T13:54:22.679Z